Gilead Sciences Statistics
NASDAQ: GILDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
166.43-0.10 (-0.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Gilead Sciences by the numbers
Gilead Sciences has a market capitalization of $206.43 billion based on 1.24B shares outstanding. With trailing EPS of $-3.13, Gilead Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.8% above its 50-day average and 17.0% above its 200-day average.
Average daily trading volume is 5.98M shares, or about $994.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GILD valuation vs. peer median
| Metric | GILD | Peer median | Difference |
|---|---|---|---|
| Market cap | $206.43B | $35.88B | +475% |
| Forward P/E | 16.4 | 15.4 | +7% |
| Avg. volume | 5.98M | 1.81M | +231% |
Peer median across 8 companies: AMGN, MRNA, ARGX, BIIB, RVMD, BNTX, EXEL, NBIX.
Valuation
- Market cap
- $206.43B
- Forward P/E
- 16.40
- Price / sales (latest FY)
- 7.01
- EPS (TTM)
- $-3.13
- Shares outstanding
- 1.24B
Price and trading
- Previous close
- 166.53
- Open
- 168.28
- Day range
- 165.80 – 170.24
- 52-week range
- 116.88 – 176.58
- 52-week change
- +31.42%
- 50-day moving average
- 157.26
- 200-day moving average
- 142.30
- Beta
- —
- Volume
- 7.56M
- Average volume
- 5.98M
Dividends and events
- Annual dividend
- $3.25
- Dividend yield
- 1.95%
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 206.43B
- Forward Pe
- 16.40
- Eps
- -3.13
- Dividend Yield
- 1.97%
- Dividend Rate
- 3.25
- Week52 High
- 176.58
- Week52 Low
- 116.88
- Avg Volume
- 5.98M
- Shares Outstanding
- 1.24B
- Ma50
- 157.26
- Ma200
- 142.30
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -5.75%
- Pct From52w Low
- 42.39%